PRRX1 promotes malignant properties in human osteosarcoma-Reference-Cited by-同舟云学术

PRRX1 promotes malignant properties in human osteosarcoma

Published:2021-01 Issue:1 Volume:14 Page:100960
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Joko Ryoji,Yamada Daisuke,Nakamura Masahiro^ORCID,Yoshida Aki,Takihira Shota^ORCID,Takao Tomoka^ORCID,Lu Ming,Sato Kohei^ORCID,Ito Tatsuo^ORCID,Kunisada Toshiyuki^ORCID,Nakata Eiji,Ozaki Toshifumi^ORCID,Takarada Takeshi^ORCID

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Progress in the chemotherapeutic treatment of osteosarcoma;Zhang;Oncol. Lett.,2018

2. Review of management issues in relapsed osteosarcoma;Vijayamurugan;Expert Rev. Anticancer Ther.,2014

3. Metastatic osteosarcoma: a challenging multidisciplinary treatment;Meazza;Expert Rev. Anticancer Ther.,2016

4. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the cooperative osteosarcoma study group (COSS);Kempf-Bielack;J. Clin. Oncol.,2005

5. Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the children's oncology group;Chou;Cancer,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival and analysis of prognostic factors for fibroblastic osteosarcoma patients: a population-based study;Translational Cancer Research;2024-07

2. Porcine transient receptor potential channel 1 (TRPC1) regulates muscle growth via the Wnt/β-catenin and Wnt/Ca2+ pathways;International Journal of Biological Macromolecules;2024-04

3. PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours;British Journal of Cancer;2024-03-06

4. Identification of potential extracellular vesicle protein markers altered in osteosarcoma from public databases;PROTEOMICS – Clinical Applications;2023-01-03

5. TPX2 regulated by miR‑29c‑3p induces cell proliferation in osteosarcoma via the AKT signaling pathway;Oncology Letters;2022-03-11